Dr. Agarwal's Health Care Limited (AGARWALEYE) — Announcement | 4 August 2026 (2 announcements)

Dr. Agarwal's Health Care Limited reported unaudited Q1 FY27 results showing 26% YoY revenue growth to ₹614 Cr, 44.6% PAT growth, and 25.2% EBITDA growth, driven by 5 new facilities and 16.3% same-store sales growth. The company added 14 new markets and expanded its geographic reach to 165 locations, with emerging market revenue share rising to 14.2%. It highlighted 500 PPP clinical innovation cases, including 36.2% growth in femtosecond laser procedures, while closing 2 underperforming facilities. The presentation emphasized organic expansion in underpenetrated clusters and a hub-and-spoke model now spanning 228 facilities across India and Africa, with surgical facilities comprising 70.7% of the network. Management indicated H2 FY27 focus on adding 19 new facilities and scaling advanced surgical techniques like Phakonit and PPP training programs.

Dr. Agarwal's Health Care held an analyst call on August 4, 2026, to discuss unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and made the audio recording available on its website.